BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes

Description

An observational study of electronic patient data to compare diabetes medications and to determine which ones offer the best balance of risks and benefits.

Conditions

Diabetes Mellitus, Type 2

Study Overview

Study Details

Study overview

An observational study of electronic patient data to compare diabetes medications and to determine which ones offer the best balance of risks and benefits.

BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes

BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes

Condition
Diabetes Mellitus, Type 2
Intervention / Treatment

-

Contacts and Locations

Wilmington

HealthCore, Inc., Wilmington, Delaware, United States, 19801

Lexington

Humana, Lexington, Kentucky, United States, 40512-4611

Boston

Brigham and Women's Hospital, Boston, Massachusetts, United States, 02115

Beachwood

Greater Plains Collaborative, Beachwood, Ohio, United States, 44122

Dallas

Baylor Scott & White, Dallas, Texas, United States, 75246

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

    Ages Eligible for Study

    30 Years to

    Sexes Eligible for Study

    ALL

    Accepts Healthy Volunteers

    No

    Collaborators and Investigators

    Brigham and Women's Hospital,

    Alexander Turchin, MD, MS, PRINCIPAL_INVESTIGATOR, Brigham and Women's Hospital

    Study Record Dates

    2024-06-30